. 1 H-NMR spectrum (500 MHz) of compound 1 in CD3OD. Figure S2 . 13 C-NMR spectrum (125 MHz) of compound 1 in CD3OD. Figure S3 . 1 H-1 H COSY spectrum (500 MHz) of compound 1 in CD3OD. Figure S4 . HSQC spectrum (500 MHz) of compound 1 in CD3OD. Figure S5 . HMBC spectrum (500 MHz) of compound 1 in CD3OD. Figure S6 . ROESY spectrum (500 MHz) of compound 1 in CD3OD. Figure S19 . HSQC spectrum (500 MHz) of compound 2 in CDCl3. Figure S20 . HMBC spectrum (500 MHz) of compound 2 in CDCl3. Figure S21 . ROESY spectrum (500 MHz) of compound 2 in CDCl3. Figure S27 . HSQC spectrum (500 MHz) of compound 3 in CDCl3. Figure S28 . HMBC spectrum (500 MHz) of compound 3 in CDCl3. Figure S29 . ROESY spectrum (500 MHz) of compound 3 in CDCl3.
S-1. Theory and Calculation Details.
The calculations were performed by using the density functional theory (DFT) as carried out in the Gaussian 03 [1] . The preliminary conformational distributions search was performed by HyperChem 7.5 software (Hypercube, Inc., Saint-Lambert, Canada). All ground-state geometries were further optimized at the B3LYP/6-31G(d) level. Conformers within a 2 kcal/mol energy threshold from the global minimum were selected to calculate the electronic transitions [2] [3] [4] [5] . The overall theoretical ECD spectra were obtained according to the Boltzmann weighting of each
